WOLVERINE ASSET MANAGEMENT LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2014$28,000
-60.6%
7,116
-51.9%
0.00%0.0%
Q1 2014$71,000
-73.4%
14,798
-67.9%
0.00%
-83.3%
Q4 2013$267,000
+330.6%
46,035
+497.6%
0.01%
+200.0%
Q2 2013$62,0007,7030.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2013
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders